Navigation Links
Merck scientist Daria Hazuda presents Bernard Fields Lecture at 20th Conference on Retroviruses and Opportunistic Infections (CROI)
Date:3/4/2013

ATLANTA, March 4, 2013 Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced its worldwide head of Antiviral Basic Research and internationally renowned scientist, Daria Hazuda, Ph.D., presented the annual Bernard Fields Lecture yesterday at the opening session of the 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013) in Atlanta, Georgia. The Bernard Fields Lecture is presented annually at the opening session of CROI and features a basic research scientist who has made important and timely contributions to virology and/or viral pathogenesis as exemplified by the career of Bernard Fields. The Fields lecture by Dr. Hazuda, titled 'Antiretroviral Drug Discovery: HIV-1 Integrase Inhibitors and Beyond' is available on the CROI website.

"The presentation of the Fields' lecture represents fitting recognition of Daria's personal accomplishments and of her teams' contributions to HIV research over the past 20 years," said Peter S. Kim, Ph.D., president, Merck Research Laboratories. "Commitment to scientific excellence and devotion to improving health remains a focus for us all at Merck."

Dr. Hazuda is recognized for her pioneering work in deciphering the basic biochemistry of the HIV integrase. In her current role, Dr. Hazuda leads Merck's efforts in the discovery of novel anti-infective agents targeting HIV, hepatitis C and antimicrobial targets. Notable research that Dr. Hazuda and Merck have been involved in recently include progress made in collaboration with leading academic scientists on improving the understanding of HIV latency and developing new ways to displace dormant virus from infected cells.


'/>"/>

Contact: Caroline Lappetito
caroline_lappetito@merck.com
267-305-7639
Merck & Co., Inc.
Source:Eurekalert

Page: 1

Related medicine news :

1. Merck and Regenstrief Institute establish evidence-based care collaboration
2. Scientists solving the mystery of human consciousness
3. Scientists uncover multiple faces of deadly breast cancer
4. Scientist awarded $1 million grant to develop tools for hepatitis C treatment discovery
5. Scientists identify major source of cells defense against oxidative stress
6. Scientists tailor cell surface targeting system to hit organelle ZIP codes
7. Scientists rewrite rulebook on breast cancer in landmark global study
8. Kessler Foundation scientist awarded $554,000 for multiple sclerosis employment research
9. Warwick scientists uncover how checkpoint proteins bind chromosomes
10. NIH scientists link quickly spreading gene to Asian MRSA epidemic
11. Joslin scientists identify important mechanism that affects the aging process
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one ... an innovative new design of the shoulder pad. The shoulder pad provides optimal ... controlling your pain while using cold therapy. By utilizing ice and water that is ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about ... intend to develop to enable prevention of a major side effect of chemotherapy ... especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as ...
(Date:10/12/2017)... D.C. (PRWEB) , ... October 12, 2017 , ... Leading ... their peers in Washington, D.C., for the 49th Congress of the International Society ... ., Vice President of the Center for Cancer and Blood Disorders at ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... the nation's first interactive health literacy software tool, and the Cancer Patient Education ... of cancer patient education, today announce a new strategic alliance. , As ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... of California Berkeley, and other leading institutions in announcing the launch of the ... to change the way animals are raised for food. , Founding members of ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... Sept. 28, 2017 Hill-Rom Holdings, Inc. (NYSE: ... conference call and webcast on Friday, November 3, 2017, ... and ending at approximately 8:30 a.m. (CDT) / 9:30 ... company,s 2017 financial performance and guidance for 2018, Hill-Rom ... to enhance operational performance, and long-range financial outlook through ...
(Date:9/25/2017)...   Montrium , an industry leader in ... IQPC Trial Master Files & Inspection Readiness Conference ... Clinical Services has selected eTMF Connect ... EastHORN, a leading European contract research organization (CRO), ... to enable greater collaboration with sponsors, improve compliance ...
(Date:9/22/2017)... 22, 2017 AVACEN Medical (AVACEN) announced that ... successfully helping those with the widespread pain associated with ... Amanda in Essex, England commented, ... hair, experiencing no sleep at all, tremendous pain, with ... cannot recommend [the AVACEN 100] enough, how this has ...
Breaking Medicine Technology: